文献速递区域麻醉与超声

外周神经阻滞辅助剂对大鼠离体神经纤维活性的影响

Effects of peripheral nerve block adjuvants with and without local anesthetic on ex vivo rodent nerve A-alpha/beta, A-delta, and C fiber activity.
PubMed 文献 · Reg Anesth Pain Med · 2026-01-16

该研究利用离体大鼠坐骨神经电生理技术,测定右美托咪定、镁、肾上腺素和酮咯酸四种辅助剂在有或无布比卡因时对A-alpha/beta、A-delta和C纤维动作电位振幅及曲线下面积的影响,计算半数有效浓度(EC50),并在临床相关高浓度下评估各辅助剂单独或联合布比卡因的效果。结果显示部分纤维的EC50可确定,但高浓度下辅助剂单独与对照相比、联合布比卡因与单用布比卡因相比均鲜有显著差异。

要点

  • 右美托咪定、镁、肾上腺素和酮咯酸对离体大鼠坐骨神经纤维有直接作用。
  • 部分辅助剂对特定纤维类型可测定EC50,但高浓度下与对照或布比卡因单用差异不大。
  • 未来需在体模型测试不同浓度和时间点以验证临床意义。

核心结论

  • 四种辅助剂对离体大鼠坐骨神经A-alpha/beta、A-delta和/或C纤维有直接作用,但高浓度下与对照或布比卡因单用相比鲜有显著差异。

研究设计与样本

  • 离体大鼠坐骨神经电生理实验,测定四种辅助剂在有或无布比卡因时对A-alpha/beta、A-delta和C纤维的EC50,并在临床相关高浓度下比较动作电位振幅、曲线下面积和达峰潜伏期。

主要发现

  • 确定了右美托咪定(A-alpha/beta、A-delta、C纤维)、镁(A-delta纤维)、肾上腺素(C纤维)和酮咯酸(A-alpha/beta和A-delta纤维)的部分EC50。
  • 高浓度下辅助剂单独与对照相比鲜有显著差异。
  • 高浓度下辅助剂联合布比卡因与单用布比卡因相比鲜有显著差异。

临床怎么用

  • 提示这些辅助剂对外周神经纤维有直接电生理作用,但临床相关高浓度下单独或联合布比卡因的附加效应有限。

局限性

  • 离体实验,未来需在体模型测试不同浓度和时间点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Preclinical and clinical studies have shown enhanced analgesia when some adjuvant medications are combined with local anesthetics during peripheral nerve (PN) blockade. However, the effects of many adjuvants on individual PN fibers, that is, A-alpha/beta, A-delta, and C, remain poorly characterized. METHODS: Using ex vivo rat sciatic nerve electrophysiology, changes in action potential amplitude (AMP) and area under the curve (AUC) for A-alpha/beta, A-delta, and C fibers were used to determine the half-maximal effective concentrations (EC50) for four adjuvants (dexmedetomidine, magnesium, epinephrine, ketorolac) with and without bupivacaine. At a clinically relevant "high" concentration, each adjuvant's effects on AMP, AUC, and latency to 100% peak AMP were evaluated with and without bupivacaine, then statistically compared with control (no drug) and bupivacaine-alone conditions. RESULTS: EC50s for the four adjuvants were determined for some fibers: dexmedetomidine (A-alpha/beta, A-delta, C fibers), magnesium (A-delta fibers), epinephrine (C fibers), and ketorolac (A-alpha/beta and A-delta fibers). At the high concentrations, adjuvants alone produced few significant differences when compared with control, and adjuvants with bupivacaine produced few significant differences when compared with bupivacaine alone. DISCUSSION: Using ex vivo electrophysiology, we identified EC50s of dexmedetomidine, magnesium, epinephrine, and ketorolac for A-alpha/beta, A-delta, and/or C fiber AMP, demonstrating that these adjuvants have direct effects on PN fibers. Future investigations may benefit by testing different concentrations of adjuvants and bupivacaine in an in vivo model incorporating a broader range of time points.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Dugan MQ, Dubus M, Flippen AM, et al. Effects of peripheral nerve block adjuvants with and without local anesthetic on ex vivo rodent nerve A-alpha/beta, A-delta, and C fiber activity. Reg Anesth Pain Med. 2026. PMID: 41545081. doi:10.1136/rapm-2025-106955

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。